JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258794

Human BRK1 (C3orf10) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

BRK1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1 and 4 bp deletion in exon1 and 88 bp insertion in exon1.

View Alternative Names

BRICK1, SCAR/WAVE actin nucleating complex subunit, BRICK1, SCAR/WAVE actin nucleating complex subunit, homolog, Brk1-like, C3ORF10 GENE, C3orf10 chromosome 3 open reading frame 10, Chromosome 3 open reading frame 10, HSPC300, Haematopoietic stem/progenitor cell protein 300, MDS027, Probable protein BRICK1, Protein BRICK1, hHBrk1

3 Images
Sanger Sequencing - Human BRK1 (C3orf10) knockout HeLa cell lysate (AB258794)
  • Sanger seq

Unknown

Sanger Sequencing - Human BRK1 (C3orf10) knockout HeLa cell lysate (AB258794)

Allele-2 : 1 bp insertion in exon1

Sanger Sequencing - Human BRK1 (C3orf10) knockout HeLa cell lysate (AB258794)
  • Sanger seq

Unknown

Sanger Sequencing - Human BRK1 (C3orf10) knockout HeLa cell lysate (AB258794)

Allele-3 : 88 bp insertion in exon1

Sanger Sequencing - Human BRK1 (C3orf10) knockout HeLa cell lysate (AB258794)
  • Sanger seq

Unknown

Sanger Sequencing - Human BRK1 (C3orf10) knockout HeLa cell lysate (AB258794)

Allele-1 : 4 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1 and 4 bp deletion in exon1 and 88 bp insertion in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258794-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human BRK1 knockout HeLa cell lysate", "number":"AB258794-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258794-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
BRK1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C3orf10 also known as ARMH4 or Armadillo Repeat Containing 4 encodes a protein with a currently limited mechanical description. This protein weighs approximately 54 kDa and is expressed in multiple tissues notably in the brain and skeletal muscle. Studies indicate it may play a role in cellular architecture or signal transduction but exact mechanical roles require further investigation.
Biological function summary

The protein product of C3orf10 may participate in cellular structural organization or intracellular signaling. Evidence suggests it functions as part of a larger protein complex though not extensively characterized. It possibly assists in linking cellular components to ensure structural integrity or facilitate signaling processes in cells.

Pathways

C3orf10 integrates into certain cellular pathways potentially involving cytoskeleton organization or signaling cascades. It associates with proteins involved in structural support and signal relay including some members of the armadillo family known for roles in cell adhesion and signaling. However the precise pathways C3orf10 participates in remain to be fully elucidated.

C3orf10 holds interest in research related to neurodegenerative conditions and muscular disorders. Alterations in its expression or function may link to conditions like amyotrophic lateral sclerosis (ALS) or dystrophin-related muscle dysfunction. C3orf10 could interact with proteins such as dystrophin or others involved in neurodegeneration highlighting its potential impact on disease pathways.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com